Multiomic Health

MultiOmic Health discovers and develops life-changing precision medicines for metabolic syndrome-derived diseases. Using a unique combination of deep longitudinal patient datasets, AI-enabled data science capabilities and experimental biology expertise, they identify patient subpopulations having their own distinct molecular-level disease drivers. These insights are used to originate and pursue their own therapeutic R&D programmes, each with corresponding patient-stratifying biomarkers. This precision medicine approach enables shorter and smaller clinical trials with inherently higher success rates.